Iambic Therapeutics, Inc. (IAM) is currently trading at $15.38 with a Wall Street consensus price target of $27.25, implying potential upside of 77.1% over the next 12 months. 4 analysts currently cover IAM, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $35.0, while the most cautious has a target of $22.0.
IAM operates in the Healthcare sector with a market capitalisation of $729M. The stock is down 18.6% year-to-date and is currently trading near the lower end of its 52-week range of $9.6 – $25.0.
Other Healthcare stocks with comparable size and valuation.
Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.
Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.
StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.
View Full Rankings →